MedPath
NMPA Approval

Telitacicept for Injection

国药准字S20210008

March 9, 2021

Drug Information

注射用泰它西普

泰爱

注射剂

80mg/支

生物制品

March 9, 2021

Company Information

Applicant Company

中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号

Manufacturing Company

中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用泰它西普 - NMPA 批准文号 | MedPath